From the category archives:

MedWatch

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall – Particulate Matter

December 16, 2014

Intravenous administration of a solution containing particulate matter may lead to local vein irritation, inflammatory reaction, aggravation of preexisting infections, allergic reactions, and systemic embolization. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View [...]

Read More Details →

Ziprasidone (Marketed as Geodon and Generics): Drug Safety Communication – Rare But Potentially Fatal Skin Reactions

December 11, 2014

Symptoms may include a rash that can spread to all parts of the body, fever, swollen lymph nodes, and inflammation of organs such as the liver, kidney, lungs, heart, or pancreas. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take [...]

Read More Details →

Dietary Supplements Containing Live Bacteria or Yeast in Immunocompromised Persons: Warning – Risk of Invasive Fungal Disease

December 9, 2014

FDA advises practitioners to approach the application of these interventions with caution. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Heart Sync Inc. Multi-function Defibrillation Electrodes: Device Correction – Connector Incompatibility with Philips FR3 and FRx Defibrillator Units

December 3, 2014

May result in a delay in therapy. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

CONMED PadPro and R2 Multi-function Defibrillation Electrodes: Device Correction – Connector Compatibility Issue With Philips FR3 and FRx Defibrillator Units

November 26, 2014

May result in a delay in therapy. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Slim-Vie: Public Notification – Undeclared Drug Ingredient

November 26, 2014

Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The [...]

Read More Details →

Super Extreme Accelerator: Public Notification – Undeclared Drug Ingredient

November 24, 2014

Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The [...]

Read More Details →

Bee Thin: Public Notification – Undeclared Drug Ingredient

November 24, 2014

Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The [...]

Read More Details →

Black Storm: Public Notification – Undeclared Drug Ingredient

November 24, 2014

Sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The [...]

Read More Details →

Bee Slim: Public Notification – Undeclared Drug Ingredient

November 24, 2014

Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The [...]

Read More Details →